BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 48 filers reported holding BIOTA PHARMACEUTIALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $31,000 | -43.6% | 15,456 | -42.2% | 0.01% | -20.0% |
| Q2 2015 | $55,000 | -83.9% | 26,756 | -77.7% | 0.01% | -72.2% |
| Q2 2014 | $341,000 | -6.8% | 119,822 | +100.0% | 0.04% | -14.3% |
| Q1 2014 | $366,000 | +73.5% | 59,911 | +19.1% | 0.04% | +55.6% |
| Q4 2013 | $211,000 | +29.4% | 50,299 | +28.7% | 0.03% | +3.8% |
| Q3 2013 | $163,000 | – | 39,085 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,471,300 | $3,384,000 | 0.82% |
| Broadfin Capital, LLC | 2,611,711 | $6,007,000 | 0.47% |
| RA Capital Management | 1,403,853 | $3,229,000 | 0.32% |
| BVF INC/IL | 350,776 | $807,000 | 0.17% |
| TOWERVIEW LLC | 160,000 | $368,000 | 0.17% |
| KNOTT DAVID M | 290,327 | $667,752,000 | 0.14% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $673,000 | 0.11% |
| Koshinski Asset Management, Inc. | 20,600 | $47,000 | 0.03% |
| Baker Brothers Advisors | 863,184 | $1,985,000 | 0.02% |
| FNY Managed Accounts LLC | 5,000 | $11,500,000 | 0.01% |